Paris - Topical treatment with a fragment of brain-derived neurotrophic factor (BDNF) may offer a unique new approach to the management of alopecia areata, Vladimir Botchkarev, M.D., Ph.D., said at the World Congress of Dermatology.
FDA Approves Lebrikizumab-lbkz for Moderate to Severe Atopic Dermatitis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Definitions and Diagnostic Criteria of Generalized Pustular Psoriasis Require Continuity, Accuracy, Researchers Report
Comparing Devices to Assess Facial Pigmentary and Inflammatory Conditions